News

This landmark head-to-head trial, evaluated more than 20,000 patients with ACS, and was presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden. Arixtra was as

The rising cost of using these ‘me-too’ drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British

Bristol-Myers Squibb has been told by the FDA that it must provide a further year of efficacy data to support its application for its developmental arthritis drug, Orencia.

This new study shows that as melanocytes (cells that protect the skin from sun damage by producing pigmentation) morph into cancer cells, they immediately reawaken a dormant cellular

Although these fungi pose little threat to people with healthy immune systems, they can cause fatal infections in those whose immune systems have been weakened by cancer treatments

Dr Adrian Bird and his colleagues have found that the “Rett Syndrome protein”, MeCP2, only binds to genes with a specific sequence of nucleotide bases. This knowledge will

The researchers used two Affymetrix GeneChip microarrays to scan the stem cell genome at a level of detail never before possible. They found previously undetectable mutations in stem

The final results of the trial, which was conducted in the UK, Ireland and the Nordic countries, showed that the combination of newer blood pressure lowering drugs reduced

“Numerous epidemiological studies have consistently demonstrated that lower hemoglobin values, reflecting a condition known as anemia, are associated with increased hospitalizations and mortality in heart failure patients,” said